CEPI Partners Panacea, THSTI For Pan Beta Coronavirus Vaccines

Panacea’s Dengue, Pneumococcal Vaccines On Track

 
• By Vibha Ravi

CEPI will provide up to $12.5m funding for Panacea Biotec and THSTI’s pan-beta coronavirus vaccine candidate, currently in the preclinical stage. Meanwhile, Panacea’s dengue and pneumococcal vaccines are on track for a 2023 launch.

Coronavirus depiction
Pan-Beta Coronavirus Vaccines Are Under Development • Source: Alamy

More from R&D

More from Scrip